Patents by Inventor Graeme Bainbridge

Graeme Bainbridge has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220106391
    Abstract: The present disclosure encompasses novel anti-NGF antibodies, antigen binding proteins and polynucleotides encoding the same. The disclosure further provides use of the novel antibodies, antigen binding proteins and/or nucleotide of the invention for the treatment and/or prevention of NGF related disorders, particularly in for the management of pain.
    Type: Application
    Filed: October 7, 2021
    Publication date: April 7, 2022
    Inventors: Lisa Marie Bergeron, Catherine J. Strietzel, Gary F. Bammert, Graeme Bainbridge
  • Publication number: 20180112193
    Abstract: The present invention relates to compositions of matter and methods of using the same in enhancing regeneration or restoring function of an injured liver. The compositions of matter are useful in the treatment of hepatic disorders, for example, in the prevention and/or treatment of acute or chronic liver disease or as a supportive therapy to improve the outcomes following liver resection or liver transplantation.
    Type: Application
    Filed: September 8, 2017
    Publication date: April 26, 2018
    Applicant: University Court Of The University Of Edinburgh
    Inventors: Stuart Forbes, David Hume, Ben Stutchfield, Deborah Gow, Graeme Bainbridge, Theodore Oliphant, Thomas L. Wilson
  • Patent number: 9951128
    Abstract: The present disclosure describes novel caninized anti-NGF antibodies, antigen binding proteins and polynucleotides encoding the same. The disclosure further describes use of the novel antibodies, antigen binding proteins and/or nucleotides of the invention for the treatment and/or prevention of NGF related disorders, particularly for the management of canine pain.
    Type: Grant
    Filed: October 6, 2016
    Date of Patent: April 24, 2018
    Assignee: Zoetis Services LLC
    Inventors: Lisa Marie Bergeron, Graeme Bainbridge, Steven Dunham, Minghua Dai
  • Publication number: 20170158756
    Abstract: The invention provides novel caninized anti-NGF antibodies (such as caninized anti-NGF antagonist antibodies and antigen binding proteins), and polynucleotides encoding the same. The invention further provides use of said antibodies or antigen binding proteins and/or nucleotides in the treatment and/or prevention of NGF related disorders, particularly pain.
    Type: Application
    Filed: October 6, 2016
    Publication date: June 8, 2017
    Inventors: Lisa Marie BERGERON, Graeme BAINBRIDGE, Steven DUNHAM, Minghua DAI
  • Patent number: 9617334
    Abstract: The present disclosure encompasses novel caninized anti-NGF antibodies, antigen binding proteins and polynucleotides encoding the same. The disclosure further provides use of the novel antibodies, antigen binding proteins and/or nucleotides of the invention for the treatment and/or prevention of NGF related disorders, particularly for the management of canine pain.
    Type: Grant
    Filed: June 6, 2013
    Date of Patent: April 11, 2017
    Assignee: Zoetis Services LLC
    Inventors: Lisa Marie Bergeron, Graeme Bainbridge, Steven A. Dunham, Minghua Dai
  • Publication number: 20160040142
    Abstract: The present invention provides of compositions of matter comprising a CSF-1 fusion protein and methods of using the same in enhancing regeneration or restoring function of an injured liver. The compositions of matter are useful in the treatment of hepatic disorders, for example, in the prevention and/or treatment of liver disease and to improve outcomes following liver surgery.
    Type: Application
    Filed: February 28, 2014
    Publication date: February 11, 2016
    Inventors: Stuart Forbes, David Hume, Ben Stutchfield, Deborah Gow, Graeme Bainbridge, Theodore Oliphant, Thomas L. Wilson
  • Publication number: 20150147318
    Abstract: The invention provides novel caninized anti-NGF antibodies (such as caninized anti-NGF antagonist antibodies and antigen binding proteins), and polynucleotides encoding the same. The invention further provides use of said antibodies or antigen binding proteins and/or nucleotides in the treatment and/or prevention of NGF related disorders, particularly pain.
    Type: Application
    Filed: June 6, 2013
    Publication date: May 28, 2015
    Inventors: Lisa Marie Bergeron, Graeme Bainbridge, Steven A. Dunham, Minghua Dai